Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years

/PRNewswire/ -- Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™...

Related Keywords

San Luigi ,Lazio ,Italy ,Orbassano ,Piemonte ,Martinez Diaz ,Urol Nephrol ,Daniele Amparore ,Minerva Urol Nephrol ,Division Of Urology ,Prnewswire Olympus Corporation ,Urology Care Foundation ,Olympus Corporation ,International Prostate Symptom Score ,Published Data Shows Long Lasting Positive Impact ,Those Suffering ,Benign Prostatic Hyperplasia ,San Luigi Hospital ,Long Term Study ,Minerva Urol ,Updated September ,Eurology Care ,Accessed November ,Int Urol ,Tind Temporarily Implanted Nitinol Device ,Lower Urinary Tract Symptoms Secondary ,Controlled Trial ,Sexual Function ,Men Treated ,Temporarily Implanted Nitinol Device ,Cancer Prostatic ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Medical Equipment ,Men 39s Interest ,Clinical Trials Amp Medical Discoveries ,